- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04082104
Assessment of Stuttering Severity in Adults and Adolescences in Conversational and Narrative Contexts
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Stuttering is a speech disorder in which the flow of speech is disrupted by involuntary repetitions and prolongations of sounds, syllables, words or phrases as well as involuntary silent pauses or blocks.
In the world, approximately 1% of the adult population suffer from stuttering. Stuttering has severe impact on the overall quality of the person's life such as anxiety, stress, shame, low self-esteem and negative affectivity .It also affects his educational attainment, his attractiveness and work life as he avoids employment.
Stuttering varies in severity, frequency and duration from situation to situation. So its dynamics are best understood within discourse contexts that involve interactions with other people. Clinicians typically rely on spontaneous conversational samples for analyzing speech disfluencies. They have good validity, but the use of a more structured form of speech may allow for more efficient, reliable elicitation of stuttering related behaviours and better understanding of the nature of stuttering.
Narration offers a more structured context than conversation because storytellers must weave together information about the characters, the circumstances and actions. Also, narration often contains more complex language than conversation and put the whole responsibility on the speaker for planning and conveying the information to the listener, compared to conversation where two or more speakers co-construct the stream of topics and comments. Thus, narration places more linguistic, cognitive and communicative demands on speakers than does conversation.
A research was done on six adult participants and showed that some of them stuttered more during conversation and others stuttered more during narration.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Locations
-
-
-
Assiut, Egypt, 71111
- Assiut University Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Age :11-50
- Gender : both sex will be included in the study
- IQ >85
- No previous therapy
Exclusion Criteria:
- 1. Presence of any other speech, language, physical or neuropsychatric disorders.
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Cross-Sectional
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
measuring the stuttering severity index in narrative and conversational contexts by using Stuttering Severity Instrument version 3 (scale ranges from very mild to very severe)
Time Frame: baseline
|
Using SSI-3 to evaluate stuttering in both conversational and narrative contexts
|
baseline
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Comparison between the stuttering severity indices in narrative and conversational contexts (comparing the results of the primary outcome) by using the Statistical Package for the Social Sciences
Time Frame: baseline
|
baseline
|
Collaborators and Investigators
Sponsor
Publications and helpful links
General Publications
- Byrd CT, Logan KJ, Gillam RB. Speech disfluency in school-age children's conversational and narrative discourse. Lang Speech Hear Serv Sch. 2012 Apr;43(2):153-63. doi: 10.1044/0161-1461(2011/10-0068). Epub 2012 Jan 23.
- Constantino CD, Leslie P, Quesal RW, Yaruss JS. A preliminary investigation of daily variability of stuttering in adults. J Commun Disord. 2016 Mar-Apr;60:39-50. doi: 10.1016/j.jcomdis.2016.02.001. Epub 2016 Feb 23.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Stuttering
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stuttering
-
University of Texas at AustinRecruitingStuttering | Stuttering, Childhood | Stuttering, Adult | Stuttering, DevelopmentalUnited States
-
University of MichiganNational Institute on Deafness and Other Communication Disorders (NIDCD)RecruitingStuttering | Stuttering, Childhood | Stuttering, AdultUnited States
-
Biruni UniversityRecruitingStuttering, AdultTurkey
-
University of PittsburghUniversity of Michigan; National Institute on Deafness and Other Communication...Recruiting
-
University of MichiganNational Institute on Deafness and Other Communication Disorders (NIDCD)RecruitingStuttering | Stuttering, ChildhoodUnited States
-
Riphah International UniversityCompletedStuttering, AdultPakistan
-
University of OxfordCompletedStuttering, DevelopmentalUnited Kingdom
-
Iran University of Medical SciencesCompletedStuttering/ DevelopmentalIran, Islamic Republic of
-
Assiut UniversityUnknownStuttering, Childhood
-
The Hong Kong Polytechnic UniversityCompletedStuttering, Adult | StammeringHong Kong
Clinical Trials on Stuttering Severity Instument version 3
-
Assiut UniversityUnknownStuttering, Childhood
-
Assiut UniversityNot yet recruiting
-
Sohag UniversityNot yet recruitingADHD Children With StutteringEgypt
-
Westfälische Wilhelms-Universität MünsterNational Paralympic Committee Germany (NPCG)CompletedCardiac Rehabilitation | Feasibility Studies | Organization and Administration | Rehabilitation ExerciseGermany
-
University of ParmaCompletedInflammatory Response | Endotoxemia | Oxidative Stress | Glucose, High BloodItaly
-
Massachusetts General HospitalCompletedNondaily SmokingUnited States
-
University of GuadalajaraRecruitingObesity | Chronic InflammationMexico
-
Meril Life Sciences Pvt. Ltd.RecruitingAortic Valve StenosisSweden, Hungary, France, Belarus, Croatia, Germany, Netherlands, New Zealand, Poland, Portugal, Slovakia, Slovenia, Spain, Italy, Brazil, Estonia, Greece